GBB Drink Lab, which makes the world’s first formulated drink that aids in rapid blood alcohol detoxification – a handy tool, has filed a lawsuit against the psychedelics biotech company FSD Pharma (NASDAQ: HUGE). 

Why? As a result of FSD Pharma’s failure to comply with a Cease-and-Desist letter sent by GBB on April 14th, 2023, GBB Drink Lab filed a $53 million complaint for material breach of a mutual nondisclosure agreement and trade secret misappropriation.

The Lawsuit

Filed on May 1st, 2023, in the U.S. District Court for the Southern District of Florida, the complaint alleges …

Full story available on

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.